Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q2 2019 · 10-Q
Revenue$65.98K$65.98K−33.1% vs Q2 2018 Net Income-$2.04M-$2.04MN/M vs Q2 2018 EPS Diluted-$0.67-$0.67— vs Q2 2018 Operating Income-$1,599,904N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$931,088— Margins · derivedOperating margin-2425.0%−1673.6 pt vs Q2 2018
Net margin-3093.5%−1855.5 pt vs Q2 2018
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end